A5102707879- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Palliative Care and End-of-Life Issues
- Cancer Risks and Factors
- Lung Cancer Diagnosis and Treatment
- Colorectal Cancer Surgical Treatments
- Lung Cancer Treatments and Mutations
- Multiple and Secondary Primary Cancers
- Esophageal Cancer Research and Treatment
- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Health Promotion and Cardiovascular Prevention
- Prostate Cancer Diagnosis and Treatment
- Polyomavirus and related diseases
- Colorectal and Anal Carcinomas
- Genetic factors in colorectal cancer
- Prostate Cancer Treatment and Research
- Nonmelanoma Skin Cancer Studies
- Head and Neck Cancer Studies
- Cervical Cancer and HPV Research
- Ovarian cancer diagnosis and treatment
- Colorectal Cancer Treatments and Studies
- Global Health Care Issues
Cancer Registry of Norway
2016-2025
Norwegian Institute of Public Health
2016-2025
KTH Royal Institute of Technology
2019-2025
National Cancer Registry
2023
Rheinmetall (Czechia)
2022
University of Oslo
1999-2021
École Polytechnique Fédérale de Lausanne
2021
Refugee Council
2019
National Cancer Registration Service
1999-2018
Oslo University Hospital
2016-2017
Oncogenic human papillomaviruses (HPVs), especially HPV type 16 (HPV-16), cause anogenital epithelial cancers and are suspected of causing the head neck.
INTRODUCTION: Rectal cancer surgery has been characterized by a high incidence of local recurrence, an occurrence which influences survival negatively. In Norway there was growing recognition that recurrence rates were related to surgeon performance and surgeons applying standardized surgical technique in the form total mesorectal excision could achieve better results. This contrasts with prevailing argument voiced many opinion leaders possibly can only be improved adjuvant or neoadjuvant...
To assess if cancers diagnosed during pregnancy or lactation are associated with increased risk of cause-specific death.In this population-based cohort study using data from the Cancer Registry and Medical Birth Norway, 42,511 women, age 16 to 49 years cancer 1967 2002, were eligible. They grouped as not pregnant (reference), pregnant, lactating at diagnosis. Cause-specific survival for all sites combined, most frequent malignancies, was investigated a Cox proportional hazards model. An...
BACKGROUND The overall age‐standardized cancer incidence rate continues to decline whereas the number of cases diagnosed each year increases. Predicting can help anticipate future resource needs, evaluate primary prevention strategies, and inform research. METHODS Surveillance, Epidemiology, End Results data were used estimate cancers (all sites) resulting from changes in population risk, age, size. authors projected 2020 nationwide rates (including top 23 cancers). RESULTS Since 1975,...
Heart disease and cancer are the first second leading causes of death in United States. Age-standardized rates (risk) have declined since 1960s for heart 1990s, whereas overall number deaths increased. We analyzed mortality data to evaluate project effect risk reduction, population growth, aging on year 2020.We used data, estimates, projections estimate predict from 1969 through 2020 apportion changes resulting risk, aging.We predicted that 2020, would decrease 21.3% among men (-73.9% 17.9%...
Greater understanding of international cancer survival differences is needed. We aimed to identify predictors and consequences diagnosis through emergency presentation in different jurisdictions six high-income countries.
Abstract Prediction of the future number cancer cases is great interest to society. The classical approach use age‐period‐cohort model for making incidence predictions. We made an empirical comparison different versions this model, using data from registries in Nordic countries period 1958–1997. have applied 15 methods 20 sites each sex Denmark, Finland, Norway and Sweden. Median absolute value relative difference between observed predicted numbers these 160 combinations site, country was...
To study the concordance between Gleason scores of needle biopsies and radical prostatectomy (RP) specimens in a population-based registry, to clarify whether depends on annual number RP assessed pathology unit, identify preoperative clinical factors that predict upgrading from score <or=6 biopsy >or=7 specimen.Through Cancer Registry Norway, we identified 1116 patients with available specimens. Concordance was evaluated using kappa coefficient, predictors were univariate multivariate...
Despite fertility-preserving initiatives, postcancer reproduction is expected to be lower than that of the general population. Using data from Cancer Registry and Medical Birth Norway, pregnancy rates were analyzed in 27,556 survivors compared those a matched comparison group ("controls") All born after 1950, diagnosed 1967 2004 at age 16-45, had an observation time date diagnosis (assigned for controls), until pregnancy, death, 46, or December 31, 2006. Cox regression was used estimate...
BACKGROUND The Norwegian Breast Cancer Screening Program started in 1996. To the authors' knowledge, this is first report using individual‐based data on invitation and participation to analyze breast cancer mortality among screened nonscreened women program. METHODS Information dates of invitation, attendance, diagnosis, emigration, death, cause death was linked by unique 11‐digit personal identification numbers assigned all inhabitants Norway at birth or immigration. In total, 699,628 ages...
Objectives As part of the International Cancer Benchmarking Partnership (ICBP) SURVMARK-2 project, we provide most recent estimates colon and rectal cancer survival in seven high-income countries by age stage at diagnosis. Methods Data from 386 870 patients diagnosed during 2010–2014 19 registries (Australia, Canada, Denmark, Ireland, New Zealand, Norway UK) were analysed. 1-year 5-year net estimated diagnosis, country, Results (One1-year) varied between (77.1% 87.5%) 59.1% 70.9% (84.8%...
Recorded dataTo validate the nine methods used in GLOBOCAN to estimate national incidence 2012 (GLOBOCAN 2012), long-term na-tional and regional mortality data as well 5-year relative survival estimates are required.Of few countries with such available, we selected Norway because of consistently high quality its cancer registry data, available nationally by region.Cancer reporting is a legal requirement linkage procedures cause death further increase completeness information.For period...
The severity of cancers is often measured in number deaths. However, years life lost (YLL) may be a more appropriate indicator impact on society. Here we have calculated the YLL adult Norway for year 2012, as well previous 15-year period. Data age composition, expected remaining life, total numbers deaths and due to cancer were retrieved from National Census Agency Statistics Norway. both sexes aged 25–99 based each individual's at death, that age. Cancer represented 25.8% all with lower...
Abstract International comparison of liver cancer survival has been hampered due to varying standards and degrees for morphological verification differences in coding practices. This article aims compare across the Cancer Benchmarking Partnership's (ICBP) jurisdictions whilst trying ensure that estimates are comparable through a range sensitivity analyses. Liver incidence data from 21 7 countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway United Kingdom) were obtained...
<b>Background:</b> Very few population based results have been presented for survival after resection lung cancer. The purpose of this study was to present long term and quantify prognostic factors survival. <b>Methods:</b> All cancer patients diagnosed in Norway 1993–2002 were reported the Cancer Registry (n = 19 582). A total 3211 underwent surgical included analysis. Supplementary information from hospitals (including co-morbidity data) collected 1993–8. Five year observed relative...
We estimated the future cancer incidence rates and numbers of cases in England up to 2020 using registration data for 1974-2003, official population projections from ONS 2023. Data were analysed an age-period-cohort model as developed Nordic countries. predict that all cancers combined there will be relatively little change age-standardised 2020. The number new per year is, however, predicted increase by 33%, 224,000 2001 299,000 This is mainly due anticipated effects growth ageing; patients...
Background. The Norwegian Rectal Cancer Project was initated in 1993 with the aims of improving surgery, decreasing local recurrence rates, survival, and establishing a national rectal cancer registry. Here we present results from Colorectal Registry (NCCR) to 2010.Material methods. A total 15 193 patients were diagnosed Norway 1993–2010, registered clinical data regarding diagnosis, treatment, locoregional recurrences distant metastases. Of these, 10 796 non-metastatic disease underwent...
The high risk of skin cancer after organ transplantation is a major clinical challenge and well documented, but reports on temporal trends in the posttransplant cutaneous squamous cell carcinoma (SCC) are few appear contradictory.